These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ocular involvement in primary central nervous system lymphoma: an increasing clinical problem? Roos DE; O'Brien PC; Crompton JL Australas Radiol; 1993 Nov; 37(4):372-4. PubMed ID: 8257339 [TBL] [Abstract][Full Text] [Related]
3. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? O'Neill BP; Dinapoli RP; Kurtin PJ; Habermann TM J Neurooncol; 1995; 25(1):67-71. PubMed ID: 8523091 [TBL] [Abstract][Full Text] [Related]
4. Role of vitreous cytology in the diagnosis of primary central nervous system lymphoma: A report of an unusual presentation. Tom JP; Gupta P; Radotra BD; Gupta N; Takkar A; Singh S; Gupta V Diagn Cytopathol; 2023 Aug; 51(8):E232-E238. PubMed ID: 37148480 [TBL] [Abstract][Full Text] [Related]
5. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients]. Siepmann K; Rohrbach JM; Duncker G; Zierhut M Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma. Tourville E; Tardif Y Can J Ophthalmol; 2003 Dec; 38(7):598-601. PubMed ID: 14740803 [No Abstract] [Full Text] [Related]
9. Primary central nervous system lymphoma: essential points in diagnosis and management. Paydas S Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229 [TBL] [Abstract][Full Text] [Related]
10. [Malignant non-Hodgkin lymphoma of the central nervous system with ocular site. Value of vitrectomy for diagnosis]. Maalouf T; Angioi-Duprez K; Guibaud I; Baty V; May T; Plenat F; Canton P; George JL J Fr Ophtalmol; 1997; 20(9):693-6. PubMed ID: 9587581 [TBL] [Abstract][Full Text] [Related]
11. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057 [TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma: presentation, diagnosis and staging. Eichler AF; Batchelor TT Neurosurg Focus; 2006 Nov; 21(5):E15. PubMed ID: 17134117 [TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma. Batchelor TT Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):379-385. PubMed ID: 27913504 [TBL] [Abstract][Full Text] [Related]
15. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Hormigo A; Abrey L; Heinemann MH; DeAngelis LM Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140 [TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphoma: from clinical presentation to diagnosis. Herrlinger U; Schabet M; Bitzer M; Petersen D; Krauseneck P J Neurooncol; 1999 Jul; 43(3):219-26. PubMed ID: 10563426 [TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma in a patient treated with natalizumab. Schweikert A; Kremer M; Ringel F; Liebig T; Duyster J; Stüve O; Hemmer B; Berthele A Ann Neurol; 2009 Sep; 66(3):403-6. PubMed ID: 19798640 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of primary central nervous system lymphoma. Han CH; Batchelor TT Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405 [TBL] [Abstract][Full Text] [Related]
20. Classification, pathogenesis and molecular pathology of primary CNS lymphomas. Paulus W J Neurooncol; 1999 Jul; 43(3):203-8. PubMed ID: 10563424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]